Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 8;22(1):390.
doi: 10.1186/s12935-022-02741-5.

Exosomal LINC00460/miR-503-5p/ANLN positive feedback loop aggravates pancreatic cancer progression through regulating T cell-mediated cytotoxicity and PD-1 checkpoint

Affiliations

Exosomal LINC00460/miR-503-5p/ANLN positive feedback loop aggravates pancreatic cancer progression through regulating T cell-mediated cytotoxicity and PD-1 checkpoint

Jun Yao et al. Cancer Cell Int. .

Abstract

Background: Long non-coding RNA (lncRNA) LINC00460 is an onco-lncRNA in a variety of cancers, including pancreatic cancer (PC). This study is aimed to investigate the regulatory mechanisms of LINC00460 in PC.

Methods: The tumor and adjacent normal tissues were collected from 73 PC patients. The expression of LINC00460, miR-503-5p, and ANLN was detected using qRT-PCR. We then analyzed the proliferation, migration, invasion, and apoptosis/cell cycle of PC cells by performing the MTT/EdU, transwell, and flow cytometry assays, respectively. The xenograft tumor model were utilized to confirm the effect of LINC00460 knockdown on PC through anti-PD-1 therapy in vivo, and the sensitivity of PANC-1 cells to the cytotoxicity of CD8+ T cells in vitro. Western blotting was used to determine the protein levels. A co-culture model was utilized to explore the effects of exosomes on macrophages.

Results: LINC00460 was up-regulated in PC tissues and cells. LINC00460 knockdown suppressed cell proliferation, migration, and invasion, facilitated cell apoptosis and G0/G1 phase arrest, and inhibited the tumor growth through anti-PD-1 therapy. Both miR-503-5p down-regulation and ANLN up-regulation reversed the effects of LINC00460 knockdown on inhibiting the proliferation, migration and invasion, and on promoting the apoptosis, G0/G1 phase arrest, and the sensitivity of PC cells to the cytotoxicity of CD8+ T cells. Exosomes were uptaken by the ambient PC cells. PANC-1 cells-derived exosomal LINC00460-induced M2 macrophage polarization accelerates the cell migration and invasion.

Conclusions: LINC00460 silencing attenuates the development of PC by regulating the miR-503-5p/ANLN axis and exosomal LINC00460-induced M2 macrophage polarization accelerates the migration and invasion of PANC-1 cells, thus LINC00460 may act as a possible therapeutic target for treating PC.

Keywords: ANLN; Exosomes; LINC00460; M2 polarization; Pancreatic cancer; miR-503-5p.

PubMed Disclaimer

Conflict of interest statement

All authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
LINC00460 is highly expressed in PC tissues and cells. A The expression of LINC00460 in PAAD tissues and normal tissues was analyzed in TCGA. *P < 0.01. B The expression of LINC00460 in PC tissues (n = 73) and adjacent tissues (n = 73) was detected by qRT-PCR. P < 0.01. C The expression of LINC00460 in lymph node metastasis or non-metastasis was detected by qRT-PCR. P < 0.01. D The expression of LINC00460 at different WHO grades was detected by qRT-PCR. P < 0.01. E Correlation between LINC00460 expression and overall survival of PC patients was assessed using Kaplan–Meier analysis. *P < 0.05. F The expression of LINC00460 in H6C7 cells and PC cell lines (ASPC-1, BxPC-3, SW1990, PANC-1 and Mia-PaCa-2) was detected by qRT-PCR. **P < 0.01 vs. the H6C7 cells group
Fig. 2
Fig. 2
LINC00460 knockdown inhibits the malignant characteristics of PANC-1 cells in vitro and suppresses the growth of tumor xenograft in vivo. A The expression of LINC00460 in PANC-1 cells was detected by qRT-PCR. B The viability (OD450) of PANC-1 cells was measured by MTT assay. C The proliferation of PANC-1 cells was determined by EdU assay (200 ×). D The apoptosis of PANC-1 cells was analyzed by flow cytometry assay. (E) The migration ability of PANC-1 cells was measured by transwell assay. F The invasion ability of PANC-1 cells was measured by transwell assay. G The protein levels of E-cadherin and N-cadherin were determined by Western blot. H The images of tumor xenograft with LINC00460 knockdown. I The tumor volumes were monitored at different time points. J The tumor weights were measured 4 weeks later. (K) Ki67 staining in PC tissues was measured by IHC assay (400 ×). **P < 0.01 vs. the sh-NC group
Fig. 3
Fig. 3
MiR-503-5p is the direct target of LINC00460. A The predicted targets of LINC00460 from databases (StarBase and TCGA) were exhibited by Venn diagram. B Five miRNAs selected from databases were detected by RIP assay in PANC-1 cells. **P < 0.01 vs. the MS2 group. C The expression of miR-503-5p in PAAD tissues and normal tissues was analyzed in TCGA. *P < 0.05. D The predicted binding site between LINC00460 and miR-503-5p. E The luciferase activity in PANC-1 cells transfected with pGL3-LINC00460 WT/pGL3-LINC00460 MUT and miR-503-5p mimics/NC was determined by DLR assay. **P < 0.01 vs. the miR-NC group. F The expression of miR-503-5p after transfection of sh-LINC00460-1/NC into PANC-1 cells was detected by qRT-PCR. **P < 0.01 vs. the sh-NC group. G The expression of miR-503-5p in tumor tissues (n = 73) and adjacent tissues (n = 73) was detected by qRT-PCR. P < 0.01. H The correlation between LINC00460 and miR-503-5p. P < 0.01, r = −0.4115. I The expression of miR-503-5p in H6C7 cells and PC cell lines (ASPC-1, BxPC-3, SW1990, PANC-1 and Mia-PaCa-2) was detected by qRT-PCR. **P < 0.01 vs. the H6C7 cells group
Fig. 4
Fig. 4
Overexpression of miR-503-5p inhibits the malignant characteristics of PANC-1 cells. A The expression of miR-503-5p after transfection of miR-503-5p mimics/NC into PANC-1 cells was detected by qRT-PCR. B The viability (OD450) of PANC-1 cells was measured by MTT assay. C The proliferation of PANC-1 cells was determined by EdU assay (200 ×). D The apoptosis of PANC-1 cells was analyzed by flow cytometry assay. E The migration ability of PANC-1 cells was measured by transwell assay. F The invasion ability of PANC-1 cells was measured by transwell assay. G The protein levels of E-cadherin and N-cadherin were determined by Western blot. **P < 0.01 vs. the miR-NC group
Fig. 5
Fig. 5
Identification of ANLN as the target gene of miR-503-5p. A Three target genes of miR-503-5p from databases (TargetScan, miRDB and TCGA) were exhibited by Venn diagram. B The predicted complementary binding site of miR-503-5p and ANLN. C The luciferase activity in PANC-1 cells transfected with pGL3-ANLN WT/pGL3-ANLN MUT and miR-503-5p mimics/NC was determined by DLR assay. **P < 0.01 vs. the miR-NC group. D The expression of miR-503-5p in tumor tissues (n = 73) and adjacent tissues (n = 73) was detected by qRT-PCR. P < 0.01. E The correlation between miR-503-5p and ANLN. P < 0.01, r = −0.339. F The correlation between LINC00460 and ANLN. P < 0.01, r = −0.3623. G The protein level of ANLN after transfection of miR-503-5p mimics/NC into PANC-1 cells was determined by western blot assay. **P < 0.01 vs. the miR-NC group. H The protein level of ANLN in H6C7 cells and PC cell lines (ASPC-1, BxPC-3, SW1990, PANC-1 and Mia-PaCa-2) were determined by western blot assay. **P < 0.01 vs. the H6C7 cells group
Fig. 6
Fig. 6
LINC00460 knockdown inhibits the proliferation, migration and invasion, and promotes the apoptosis and G0/G1 phase arrest of PANC-1 cells by regulating miR-503-5p/ANLN. A The protein level of ANLN after transfection of pcDNA-ANLN/NC into PANC-1 cells was measured by western blot assay. **P < 0.01 vs. the pcDNA-NC group. B The expression of miR-503-5p after transfection of miR-503-5p inhibitor/miR-NC into PANC-1 cells was measured by qRT-PCR. **P < 0.01 vs. the miR-NC group. C The viability (OD450) of PANC-1 cells was measured by MTT assay. D The apoptosis of PANC-1 cells was analyzed by flow cytometry assay. E The cell cycle of PANC-1 cells was analyzed by flow cytometry assay. F The migration ability of PANC-1 cells was measured by transwell assay. G The invasion ability of P PANC-1 cells was measured by transwell assay. H The protein levels of E-cadherin and N-cadherin were determined by Western blot. I The proliferation of PANC-1 cells was determined by EdU assay (200 ×). **P < 0.01 vs. the sh-NC group, ##P < 0.01 vs. the sh-LINC00460 group
Fig. 7
Fig. 7
Silencing of LINC00460 reduces the tumor growth of PC through anti-PD-1 therapy and enhances the sensitivity of PANC-1 cells to cytotoxicity of tumor-reactive T cells via regulating the miR-503-5p/ANLN axis. A The images of tumor xenograft with different treatments. B The tumor volumes were monitored at different time points. C The tumor weight in mice of each group after 2 weeks of injection. **P < 0.01 vs. the IgG + sh-NC group; ##P < 0.01 vs. the anti-PD-1 + sh-NC group. D Ki67 staining in PC tissues was measured by IHC assay (400 ×). E The sensitivity of PANC-1 cells to the cytotoxicity of tumor-reactive T cells in different treatments. **P < 0.01 vs. the sh-NC group; #P < 0.05, ##P < 0.01 vs. the sh-LINC00460 group
Fig. 8
Fig. 8
Exosomal-LINC00460 facilitates M2 macrophage polarization. A The morphological characteristics of exosomes which was round membranous vesicle were observed by a TEM. Scale bar: 200 nm. B The levels of exosomes surface marker (TSG101, CD63 and CD81) were detected by Western blot. C The mRNA level of macrophage marker CD68 was detected by qRT-PCR. **P < 0.01 vs. the THP-1 cells group. D Uptake of exosomes was observed by a confocal microscope (400 ×). E The expression of LINC00460 in exosomes secreted by PANC-1 cells was detected by qRT-PCR. **P < 0.01 vs. the pcDNA-NC group. F The mRNA levels of M2 polarized markers (CD163, CD206, ARG1 and IL-10) were detected by qRT-PCR. *P < 0.01 vs. the control group; ##P < 0.01 vs. the Exo-pcDNA-NC group. (G) The mRNA levels of M1 polarized markers (iNOS and IL-12) were detected by qRT-PCR. *P < 0.01 vs. the control group; ##P < 0.01 vs. the Exo-pcDNA-NC group
Fig. 9
Fig. 9
M2 macrophage polarization aggravates the migration and invasion of PANC-1 cells. A The migration ability of PANC-1 cells in a co-culture model was measured by transwell assay. B The invasion ability of PC cells in a co-culture model was measured by transwell assay. C The protein levels of E-cadherin and N-cadherin were determined by western blot assay. *P < 0.05, **P < 0.01 vs. the PANC-1 cells group; ##P < 0.01 vs. the PANC-1 + M + Exo-NC group

References

    1. Lankadasari MB, Aparna JS, Mohammed S, James S, Aoki K, Binu VS, Nair S, Harikumar KB. Targeting S1PR1/STAT3 loop abrogates desmoplasia and chemosensitizes pancreatic cancer to gemcitabine. Theranostics. 2018;8(14):3824–3840. doi: 10.7150/thno.25308. - DOI - PMC - PubMed
    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. doi: 10.3322/caac.21442. - DOI - PubMed
    1. McGuigan A, Kelly P, Turkington RC, Jones C, Coleman HG, McCain RS. Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol. 2018;24(43):4846–4861. doi: 10.3748/wjg.v24.i43.4846. - DOI - PMC - PubMed
    1. Zhao Z, Liu W. Pancreatic cancer: a review of risk factors, diagnosis, and treatment. Technol Cancer Res Treat. 2020;19:1533033820962117. doi: 10.1177/1533033820962117. - DOI - PMC - PubMed
    1. Hui B, Ji H, Xu Y, Wang J, Ma Z, Zhang C, Wang K, Zhou Y. RREB1-induced upregulation of the lncRNA AGAP2-AS1 regulates the proliferation and migration of pancreatic cancer partly through suppressing ANKRD1 and ANGPTL4. Cell Death Dis. 2019;10(3):207. doi: 10.1038/s41419-019-1384-9. - DOI - PMC - PubMed